-
- News
- Books
Featured Books
- smt007 Magazine
Latest Issues
Current IssueThe Rise of Data
Analytics is a given in this industry, but the threshold is changing. If you think you're too small to invest in analytics, you may need to reconsider. So how do you do analytics better? What are the new tools, and how do you get started?
Counterfeit Concerns
The distribution of counterfeit parts has become much more sophisticated in the past decade, and there's no reason to believe that trend is going to be stopping any time soon. What might crop up in the near future?
Solder Printing
In this issue, we turn a discerning eye to solder paste printing. As apertures shrink, and the requirement for multiple thicknesses of paste on the same board becomes more commonplace, consistently and accurately applying paste becomes ever more challenging.
- Articles
- Columns
Search Console
- Links
- Media kit
||| MENU - smt007 Magazine
Promex Receives CA FDB Manufacturing License for Class II, Class III Medical Devices
June 24, 2019 | PromexEstimated reading time: 1 minute
Promex, a provider of microelectronics assembly technology, is now licensed to manufacture Class II and Class III medical devices by the State of California Food and Drug Branch (FDB) of the Food and Drug Administration (FDA). This license indicates that the FDB has authorized Promex to operate under the rigorous quality guidelines of California's Device Manufacturing Licensing Laws, including compliance with California Health and Safety Code requirements, all applicable state laws, and the federal Good Manufacturing Practice (GMP) and Quality System Regulations (QSR).
Research by McKinsey & Company found that of the $380 billion in global sales for medical devices in 2017, poor quality cost device OEMs an estimated $12 billion, despite an investment by manufacturers of close to $24 billion in quality procedures and processes. According to Promex Director of Quality and Regulatory Compliance Hassan Sorkhabi, the CA FDB license strengthens Promex's position within the medical device industry as a quality-focused provider of complex engineering and heterogeneous assembly solutions.
“Every change or modification to the design or manufacture of a complex biomedical device creates a new set of variables. We understand the importance of thorough documentation and verified processes and do everything possible to ensure quality for our customers. By incorporating risk management in the Promex quality policy, our organization is adopting a preventive-action approach to most activities performed under our Quality Management System (QMS)—a practice aligned with the latest ISO 13485:2016 and ISO 9001-2015 expectations. As a CA FDB-licensed medical device manufacturing services provider, we use Risk Management and pFMEA after QMS policy implementation for continuous improvement,” Sorkhabi said.
Promex is exhibiting at Sensors 2019 in San Jose, Calif. in Booth 1229 and at IMAPS Advanced SiP (system in package) in Monterey, Calif. Both events run June 25-27, 2019 and will enable Promex to deliver its message of the importance of quality and the benefits of heterogeneous assembly for the production of sensors, sensor-integrated systems, SiPs, and complex medical devices to a more than 7,000 attendees.
About Promex
Promex provides design-for-manufacturing services coupled with materials science expertise and broad assembly capabilities for small- to mid-volume onshore production. Located in Silicon Valley since 1975, Promex features Class 100 and Class 1000 cleanrooms. The company is ISO 13485:2016 and ISO 9001:2015 certified, ITAR registered and licensed by the State of California Food and Drug Branch to manufacture Class II and Class III medical devices.
Suggested Items
China Overtakes Germany and Japan in Robot Density
11/22/2024 | IFRChina's adoption of robots continues at a rapid pace: The country has surpassed Germany and Japan in the ratio of robots to factory workers, taking third place in the world in 2023.
PCB Design Software Market Expected to Hit $9.2B by 2031
11/21/2024 | openPRThis report provides an overview of the PCB design software market, detailing key market drivers, challenges, technological advancements, regional dynamics, and future trends. With a projected compound annual growth rate (CAGR) of 13.4% from 2024 to 2031, the market is expected to grow from USD 3.9 billion in 2024 to USD 9.2 billion by 2031.
SIA Applauds CHIPS Award for Semiconductor Research Corporation’s SMART USA Institute
11/21/2024 | SIAThe Semiconductor Industry Association (SIA) released the following statement from SIA President and CEO John Neuffer commending the announcement that the U.S. Department of Commerce and the Semiconductor Research Corporation Manufacturing Consortium Corporation (SRC) are entering negotiations for the Commerce Department to provide SRC $285 million to establish and operate the CHIPS Manufacturing USA Institute for Digital Twins.
SIA Praises Finalization of CHIPS Investments for GlobalFoundries Manufacturing Projects
11/21/2024 | SIAThe Semiconductor Industry Association (SIA) released the following statement from SIA President and CEO John Neuffer applauding finalization of semiconductor manufacturing investments announced by the U.S. Department of Commerce and GlobalFoundries.
IPC Issues Clarion Call for EU to Reclaim Leadership in Electronics Manufacturing
11/21/2024 | IPCIPC released a synopsis of its recent white paper, Securing the European Union’s Electronics Ecosystem. This condensed document presents a comprehensive overview of the current challenges in Europe’s electronics manufacturing industry and shares actionable steps to help the EU achieve a stronger, more autonomous ecosystem.